Keskin Fatih, Karatas Ahmet, Albayrak Mustafa, Bıyık Ismail, Erkan Müşerref, Demirin Hilmi, Dilbaz Serdar
Department of Obstetrics and Gynecology, Faculty of Medicine, Abant Izzet Baysal University, 14280, Golkoy, Bolu, Turkey.
Medicina (Kaunas). 2013;49(10):435-8.
BACKGROUND AND OBJECTIVE. It is unclear how immune tolerance develops to a semiallograft fetus in pregnancy. Human leukocyte antigen G (HLA-G) expressed by extravascular trophoblasts plays an important role in the recognition of the gestational tissues as self and the development of immune tolerance against the gestational tissues by the maternal immune system. The soluble form of the HLA-G (sHLA-G) molecule in the maternal serum is also reported to contribute to the prevention of rejection during pregnancy. The aim of the study was to compare the maternal serum sHLA-G levels of the women with missed abortions and control subjects with uncomplicated pregnancies. MATERIAL AND METHODS. The prospective cross-sectional study involving 40 with missed abortions and 40 control women, matched by age, gestational age, and body mass index, was carried out. The study group consisted of the women with singleton pregnancies, who were diagnosed with a missed abortion. Only the patients who were confirmed to have an uncomplicated term delivery during follow-up were included in the control group. The serum sHLA-G level was compared between the groups. RESULTS. There was no significant difference in the mean serum sHLA-G levels in terms of gravidity (P=0.761) and a history of abortion (P=0.379) in the control group. The median serum sHLA-G level in the missed abortion group was significantly lower compared with the control group (16.8 [8.5-35.8] vs. 26 [11-135] U/mL, P<0.001). All the women in the control group had uncomplicated term deliveries. CONCLUSION. Our results showed that the women with missed abortions had significantly lower serum sHLA-G levels compared with the healthy pregnant controls, which may have potentially played a role in the impairment of physiological immunological tolerance during pregnancy. However, the determination of the exact role and the potential clinical utility of maternal serum sHLA-G for the detection/prediction of a missed abortion risk requires further detailed studies.
背景与目的。目前尚不清楚孕期母体如何对半同种异体胎儿产生免疫耐受。血管外滋养层细胞表达的人类白细胞抗原G(HLA - G)在将妊娠组织识别为自身组织以及母体免疫系统对妊娠组织产生免疫耐受的过程中发挥着重要作用。据报道,母体血清中可溶性HLA - G(sHLA - G)分子也有助于预防孕期排斥反应。本研究旨在比较稽留流产妇女与正常妊娠对照者的母体血清sHLA - G水平。材料与方法。进行了一项前瞻性横断面研究,纳入40例稽留流产妇女和40例对照妇女,两组在年龄、孕周和体重指数方面相匹配。研究组由诊断为稽留流产的单胎妊娠妇女组成。对照组仅纳入随访期间证实为足月顺产且无并发症的患者。比较两组间血清sHLA - G水平。结果。对照组中,平均血清sHLA - G水平在妊娠次数(P = 0.761)和流产史(P = 0.379)方面无显著差异。稽留流产组血清sHLA - G水平中位数显著低于对照组(16.8 [8.5 - 35.8] 对 26 [11 - 135] U/mL,P < 0.001)。对照组所有妇女均足月顺产且无并发症。结论。我们的结果表明,与健康妊娠对照组相比,稽留流产妇女血清sHLA - G水平显著降低,这可能在孕期生理免疫耐受受损中发挥了作用。然而,确定母体血清sHLA - G在检测/预测稽留流产风险方面的确切作用和潜在临床应用价值还需要进一步详细研究。